Turning off one signal made immune cell therapy work better in mice
Original title: Depletion of IL-10 in CAR-NK cells augments reprogramming of the tumor microenvironment and ameliorates therapeutic efficacy.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This version was only tested in lab dishes and in mice.
The short version
Scientists changed an immune cell treatment for brain tumors so it stopped making a signal that calms the immune system, and it fought tumors better in mice.
What was studied. Researchers worked with NK-92/5.28.z cells. These are natural killer immune cells that have been engineered to attack tumor cells that carry HER2. The plain version of these cells is being tested in an early trial in people with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. In this study, the team changed the cells so they could not release a substance called IL-10, then tested them in the lab and in mice with glioblastoma.
What they found. The change did not affect how well the cells grew or how well they killed tumor cells. The changed cells did a better job of switching on other immune cells that help fight tumors. They also stopped a change in nearby immune cells that can help a tumor hide. In mice with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, the changed cells fought the tumor better, and fewer immune-calming cells moved into the tumor.
What this means, and what it doesn't
What it could mean: This points to a way to make an immune cell therapy for brain tumors stronger. The plain version of these cells is already in an early safety trial in people. If this change holds up, it could shape a future version of that treatment.
What it doesn't mean: This does not mean there is a new treatment. This work was done in the lab and in mice. The changed cells have not been given to a single person. Results in mice often do not carry over to people. This is not a cure, and it is not something a doctor can offer today.
Source: PubMed, June 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.